EDIT
Editas Medicine Inc.
Company Overview
| Mkt Cap | $236.91M | Price | $3.08 |
| Volume | 6.38M | Change | +2.33% |
| P/E Ratio | -1.0 | Open | $3.01 |
| Revenue | $32.3M | Prev Close | $3.01 |
| Net Income | $-237.1M | 52W Range | $0.91 - $4.54 |
| Div Yield | N/A | Target | $3.67 |
| Overall | 47 | Value | 40 |
| Quality | 36 | Technical | 66 |
No chart data available
Stock Overview
Updated DailyEditas Medicine Inc. (EDIT) is a leading Healthcare company in the Biotechnology industry, currently trading at $3.08 with a market capitalization of $236.91 million. The stock is trading in the middle of its 52-week range, demonstrating concerning quality fundamentals with a MarketXLS quality score of 36.
Today's trading session shows EDIT with a volume of 6.38 million shares. The stock opened down 0.00% from yesterday's close of $3.01. Current analyst estimates project earnings of $-1.65 per share for this year, with next year targeting $-1.02.
EDIT demonstrates positive technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including MYMX, MRVI, NBIX, NSTG.
Key investment considerations for EDIT include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 19.2%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 11:16 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | EDIT | $3.08 | +2.3% | 6.38M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |